Compound and use thereof in treating autoimmune diseases

A method for treatment of cancer, the method comprising administering a pharmaceutical composition to a subject in need thereof,

• wherein the pharmaceutical composition comprises a compound represented by Formula 1 below, a stereoisomer thereof or a pharmaceutically acceptable salt thereof,
• wherein the cancer is any one selected from the group consisting of melanoma, liver cancer, gliocytoma, ovarian cancer, colorectal cancer, head and neck cancer, bladder cancer, kidney cell cancer, stomach cancer, breast cancer, metastatic cancer, prostate cancer, gallbladder cancer, pancreatic cancer, blood cancer, skin cancer and lung cancer:
• (wherein, A is hydrogen, halogen, a hydroxyl group, a C1-C3 alkyl group, a C2-C3 alkenyl group, a C2-C3 alkynyl group, a C1-C3 alkoxy group, dimethylamine, —NO2, —CN, —COOR2 or —S(═O)2R2,
• B is hydrogen, a C1-C3 alkyl group, a phenyl group, an acetyl group, —CH2C(═O)OR2, —C(═O)OR2 or —S(═O)2R2,
• R1 is a substituted or unsubstituted 5-7 membered heterocyclic ring or —NH2, and
• R2 is a C1-C3 alkyl group).